Skip to main content

This job has expired

You will need to login before you can apply for a job.

Data Scientist, Bioinformatics

Employer
Precision BioSciences, Inc.
Location
Durham, NC, United States
Start date
Jun 21, 2021

View more

Job Details

The Data Scientist, Bioinformatics will be a key member of the Core Technology team and will develop and implement software tools and algorithms focusing on Next Generation Sequencing (NGS) data to advance ARCUS nuclease development and improve genome editing outcome analysis.

The Data Scientist will work closely with Genomics team members to improve and polish current in-house software and translate scripts into software for general scientific consumption. The individual will also leverage current literature to propose and implement new data analysis pipelines that complement and advance the current system of genomic analysis as well as run current analysis pipelines as needed.

The ideal candidate will have extensive experience and knowledge in NGS data analysis. They will have a proven track record of software development for data analytics or bioinformatics applications. The candidate must have a high level of independence to carry out their responsibilities with minimal supervision.

Essential Duties and Responsibilities

Reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions of this position. This list contains the major duties and requirements of the job and is not all-inclusive. Incumbent(s) may be expected to perform role-related duties other than those contained in this document.

  • Leverage advanced computation approaches and collaborate with Genomics team members to create advanced assays for genome editing outcomes
  • Analyze experimental data produced by next-generation sequencing (NGS) including RNAseq and indel analysis
  • Maintain current and develop new computational and bioinformatic tools
  • Develop visualization tools for large scale genomic projects
  • Perform additional duties and responsibilities, as assigned


Qualifications

The requirements listed below are representative of the knowledge, skill, and/or ability required to perform this job successfully.

Required:

  • PhD in Computational Biology, Bioinformatics or related field or Masters degree and 2+ years of experience in Computational Biology, Bioinformatics or related fields, or equivalent combination of training and experience
  • Proficiency using Python for data analysis
  • Proficient in NGS data processing in a Linux computing environment
  • Some experience in R, shell scripting
  • Foundation in basic genomics concepts
  • Familiarity with publicly available bioinformatics databases, tools, algorithms, and websites, such as NCBI, UCSC, ENSEMBL, ENCODE, 1000 Genomes or NHGRI
  • Experience using visualization tools (ggplot2, seaborne, etc.)
  • Basic understanding of statistics and algorithms associated with genomics analysis
  • Experience working independently and within a team depending on project needs
  • Strong communications skills


Preferred:

  • Software engineering experience with Python
  • Experience in multiple NGS assays such as RNAseq, bisulfite sequencing, or single cell analysis
  • Versioning software (git, etc.)
  • Experience using Rmarkdown or Jupyter notebooks
  • Experience with SQL databases


Travel Requirements
  • This position requires little to no travel.


Location

This is a primarily office-based position associated with the main headquarters in downtown Durham, NC. For the time being, this role will be able to function remotely in accordance with company safety guidelines throughout the duration of the pandemic but is subject to change as needed.

Precision BioSciences, Inc. (Nasdaq: DTIL), is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS genome editing platform. This isnt just a statement supporting the products that were developing its a statement that speaks to our collective desire to do our part in improving the lives of those around us. ARCUS is a highly specific and versatile genome editing platform designed with therapeutic safety, delivery, and control in mind. Using ARCUS, Precision is developing allogeneic CAR T and in vivo gene correction therapies for cancer and genetic diseases. Our team includes pioneers in genome editing, leaders in business, and a full staff of talented and committed people who are excited to be a part of medical and scientific breakthroughs. For additional information, please visit www. precisionbiosciences.com

Precision BioSciences actively fosters an inclusive environment to ensure we attract and retain the best talent; we value diversity of life experiences and perspectives; and we encourage innovation in pursuit of our mission. We provide equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, gender identity or expression, national origin, age, disability, genetic information, marital status, amnesty, or status as a covered veteran in accordance with applicable federal, state and local laws. Precision BioSciences complies with applicable state and local laws governing non-discrimination in employment in every location in which the company has facilities. This policy applies to all terms and conditions of employment, including, but not limited to, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation, and training.

Company

Precision BioSciences, Inc. (Nasdaq: DTIL) is a clinical stage gene editing company developing in vivo gene editing and ex vivo allogeneic CAR T therapies with its highly precise and versatile ARCUS genome editing platform. ARCUS uses sequence-specific DNA-cutting enzymes, or nucleases designed for gene knock out, as well as highly sophisticated edits for gene insertion and/or gene repair. Precision’s in vivo gene editing pipeline consists of wholly-owned preclinical candidates for primary hyperoxaluria type 1 (PBGENE-PH1), familial hypercholesteremia (PBGENE-PCSK9) and chronic hepatitis B (PBGENE-HBV). It has also partnered with Lilly to develop candidates for Duchenne muscular dystrophy and two other programs targeting the liver and CNS. Precision’s allogeneic CAR T pipeline consists of multiple investigational candidates in early-stage clinical trials, including its first and second generation CD19 targeting candidates PBCAR0191 and PBCAR19B for relapsed and/or refractory (R/R) non-Hodgkin and B-cell lymphoma patients. Precision has also prioritized development of PBCAR269A, its BCMA targeted candidate in combination with a gamma secretase inhibitor for R/R patients with multiple myeloma. Precision BioSciences and its in-house manufacturing facility for AAV, mRNA, and CAR T cells is based in Durham, North Carolina. For more information about Precision BioSciences please visit www.precisionbiosciences.com

Stock Symbol: DTIL

Stock Exchange: NASDAQ

Company info
Website
Phone
919-314-5512
Location
302 East Pettigrew Street
Durham
North Carolina
27701
US

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert